Advanced non-small-cell lung cancer: adjunctive interferon gamma in induction and maintenance therapy.

C Prior,S Oroszy,W Oberaigner,G Ambrosch,A Mohn-Staudner,W Pfeifer,R Pirker, H Huber

Journal of cancer research and clinical oncology（1999）

引用 8|浏览2

暂无评分

摘要

In patients with advanced NSCLC, an adjunctive dose of 100 microg IFNgamma, given three times weekly in the induction and maintenance phase, is feasible. Survival data seem favourable so this regimen may warrant further investigation in a phase III study.

查看译文

关键词

non-small-cell lung cancer,chemotherapy interferon gamma,phase II study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要